Epigenomics2026ReviewNon-viral Gene DeliveryDrug Delivery
1. Synthetic mRNA engineering beyond prophylactic infectious disease vaccines: epigenomic and molecular reprogramming of diseased cells
Mustafa Am, Kareem Si, Raouf Cg, Ahmed Sm
The clinical validation of mRNA-based COVID-19 vaccines in 2020-2021 accelerated the development of synthetic messenger RNA as a precision therapeutic platform beyond infectious disease prevention. Unlike gene therapy approaches that permanently modify genomic DNA, synthetic mRNA enables transient protein expression…
- RNA therapeutics
- Therapeutic mRNA
- cell identity
- chromatin reprogramming
- epigenome editing
- lipid nanoparticles (LNPs)
- precision medicine
